Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing

Although nintedanib is overwhelmingly prescribed to elderly patients, this is the first study to demonstrate that ageing does not impact the efficacy of nintedanib. This study sheds light on the utility of aged animal models in pulmonary fibrosis. https://bit.ly/3zA9RC5

Detalles Bibliográficos
Autores principales: Kato, Kosuke, Shin, Yoon-Joo, Palumbo, Sunny, Papageorgiou, Ioannis, Hahn, Seongmin, Irish, Joseph D., Rounseville, Skye P., Krafty, Robert T., Wollin, Lutz, Sauler, Maor, Hecker, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613836/
https://www.ncbi.nlm.nih.gov/pubmed/34531276
http://dx.doi.org/10.1183/13993003.00759-2021
Descripción
Sumario:Although nintedanib is overwhelmingly prescribed to elderly patients, this is the first study to demonstrate that ageing does not impact the efficacy of nintedanib. This study sheds light on the utility of aged animal models in pulmonary fibrosis. https://bit.ly/3zA9RC5

Ejemplares similares